Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients
Cancer Journal - United States
doi 10.1097/ppo.0000000000000220
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)